arrow
Y

Yuji Ikeda

Juntendo University
H指数:28
被引数:2,441

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Texture and Color Enhancement Imaging for the Kyoto Classification of Gastritis: Evaluation of Visibility and Color Differences

针对胃炎京都分类的纹理和颜色增强成像:可见度和颜色差异评估

2026-02-140
OAAI
Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis
2024-09-200
OAAI
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin

整合的基因组/表观基因组分析对透明细胞卵巢癌的亚型进行分层,突出其细胞起源

2024-08-131
OAAI
Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3
2023-11-2410
OAAI
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
2021-04-0116
OAAI
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo

母体胚胎亮氨酸拉链激酶 (MELK) 的高表达影响卵巢癌患者的临床结局,其抑制作用可抑制卵巢癌细胞的离体生长

2020-01-018
OAAI
Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma
2018-08-1314
OAAI
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma
2018-07-036
OAAI
Clinical utility of CA-125 in the management of uterine carcinosarcoma
2018-01-016
OAAI